Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 64,827 $ 165,586
Restricted cash 2,518 2,518
Short-term investments 43,833 0
Accounts receivable, net of allowance of $0 and $39, respectively 3,417 2,629
Prepaid expenses and other current assets 4,275 6,264
Contract assets 5,502 1,678
Total current assets 124,372 178,675
Property and equipment - net 83,899 70,551
Goodwill 9,393 9,393
Investment in equity method investees 5,159 4,002
Intangible assets - net 2,199 2,480
Satellite procurement work in process 35,761 40,102
Other assets 346 560
Total assets 261,129 305,763
Current liabilities:    
Accounts payable and accrued liabilities 13,877 10,837
Amounts payable to equity method investees 1,537 5,613
Contract liabilities - current 4,931 11,266
Other current liabilities 2,835 2,819
Total current liabilities 23,180 30,535
Liability for estimated contract losses 3,384 6,054
Long-term contract liabilities 0 568
Derivative liabilities 13,431 16,925
Long-term debt - net of current portion 72,425 71,408
Other liabilities 5,162 653
Total liabilities 117,582 126,143
Commitments and contingencies (Note 17)
Stockholders’ equity:    
Class A common stock, $0.0001 par value-authorized, 300,000 shares; issued, 120,926 and 117,160 shares; outstanding, 118,453 shares and 114,452 shares as of June 30, 2022 and December 31, 2021, respectively. 12 11
Additional paid-in capital 660,710 650,518
Accumulated deficit (517,175) (470,909)
Total stockholders’ equity 143,547 179,620
Total liabilities and stockholders’ equity $ 261,129 $ 305,763